FFAR2 and metabolic dysfunction-associated steatotic liver disease: The activation of G protein-coupled receptor 43 (GPR43) and subsequent hepatic lipogenesis is the mechanism through which SCFAs (acetate and propionate) contribute to NAFLD development46.